Body Compartment PK for New HIV Pre-exposure Prophylaxis Modalities
Phase of Trial: Phase I
Latest Information Update: 13 Feb 2018
At a glance
- Drugs Cobicistat/elvitegravir/emtricitabine/tenofovir alafenamide (Primary) ; Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Pharmacodynamics
- 07 Feb 2018 Planned End Date changed from 1 Dec 2017 to 1 Sep 2018.
- 07 Feb 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Sep 2018.
- 09 Apr 2017 Status changed from not yet recruiting to recruiting.